Graham Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
2025
Q4
$654K Sell
2025
Q3
$2.03M Buy
2025
Q2
$1.96M Buy
2025
Q1
$1.02M Buy
2024
Q4
$731K Buy
2024
Q1
Sell
2023
Q4
$388K Buy
2023
Q3
$266K Sell
2023
Q2
$265K Buy
2022
Q4
Sell
2022
Q3
$314K Sell
2022
Q2
$1.72M Buy